Baseline testing in cluster randomised controlled trials: should this be done?

Jaime Bolzern(University of York), David Torgerson(University of York), Alex Mitchell(University of York)
BMC Medical Research Methodology
May 17, 2019
10.1186/s12874-019-0750-8
Cited by 46

Related Papers

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial
|The Lancet|2005|976
CONSORT 2025 statement: updated guideline for reporting randomised trials
|BMJ|2025|847
Guidelines for diagnosis and management of osteoporosis
|Osteoporosis International|1997|793
Understanding controlled trials: What are pragmatic trials?
|BMJ|1998|721